The prevalence of viral hepatitis and HIV infections in patients with congenital bleeding disorders.
Patients with clotting disorders, including hemophilias A and B, and von Willebrand Disease generally receive pooled human blood products, and are at high risk for HIV-1 and hepatitis A, B and C viral infection. This retrospective study describes patients receiving treatment at a federally funded Hemophilia Treatment Center (HTC) from 1998 - 2002 and assesses the prevalence of viral infection. In addition, current rates of viral infection are compared to 1984-1996 rates.
Jubelirer
Steven J
SJ
CAMC Health Education and Research Institute, Charleston, USA.
Arden
Donna
D
Jones
James W
JW
D000328:Adult; D025861:Blood Coagulation Disorders, Inherited / Q000097:blood / Q000453:epidemiology*; D015153:Blotting, Western / Q000379:methods; D015897:Comorbidity; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000097:blood / Q000453:epidemiology*; D006518:Hepatitis Viruses / Q000302:isolation & purification; D006525:Hepatitis, Viral, Human / Q000097:blood / Q000453:epidemiology*; D006801:Humans; D015995:Prevalence; D012189:Retrospective Studies; D014903:West Virginia / Q000453:epidemiology